Lesotho gains access to Global Fund's $100m RED programme for HIV/AIDS:
This article was originally published in Clinica
Executive Summary
Lesotho has become the fourth country to gain access to investments in HIV diagnostics and care under the Global Fund to Fight AIDS, Tuberculosis and Malaria's $100m RED programme. Joining the governments of Rwanda, Swaziland and Ghana, Lesotho's ministry of finance will be responsible for investing in screening to prevent mother-to-child HIV transmission and in general HIV testing, among other activities. The RED programme was established in 2006 to engage the private sector in raising public awareness and funding specifically for HIV/AIDS in Africa (see Clinica No 1206, p 10). $57m of the $100m pledged so far to the RED programme have been disbursed.
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.